Meridian Bioscience: Fiscal 4Q Earnings Snapshot

November 8, 2018

CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Thursday reported fiscal fourth-quarter earnings of $5.4 million.

On a per-share basis, the Cincinnati-based company said it had profit of 13 cents. Earnings, adjusted for one-time gains and costs, came to 20 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 16 cents per share.

The diagnostic test maker posted revenue of $53.1 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $51.2 million.

For the year, the company reported profit of $23.8 million, or 56 cents per share. Revenue was reported as $213.6 million.

Meridian Bioscience expects full-year earnings to be 74 cents to 76 cents per share.

Meridian Bioscience shares have risen 21 percent since the beginning of the year. The stock has climbed 16 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIVO at https://www.zacks.com/ap/VIVO

Update hourly